Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhavesh Shah

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Materials (Basel, Switzerland)|December 17, 2024
Measurement of Sorption Isotherms to Guide Mixed Display of Archaeological Iron, Bone, and GlassDavid Thickett, Antanas Mėlinis, Bhavesh Shah
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 21, 2022
Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myelomaBhavesh Shah, Joy Gray, Ivo Abraham, et al.
Digestive Diseases and Sciences|October 7, 2015
The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel DiseaseTaha Qazi, Bhavesh Shah, Mohammed El-Dib, et al.
Inflammatory Bowel Diseases|October 19, 2016
ReplySamantha Zullow, Sharmeel K Wasan, Bhavesh Shah, et al.
Journal of Maxillofacial and Oral Surgery|October 24, 2022
Cirsoid Aneurysm of Occipital Artery-Rare of the RarestPrashant Punia, Sonal Bhavesh Shah, Tanvi Eknath Malankar, et al.
Cureus|June 14, 2022
Accessory Spleen: A Rare and Incidental Finding in the Stomach WallSophie G Trujillo, Sherif Saleh, Ryan Burkholder, et al.
Perspectives in Clinical Research|November 25, 2024
Comparative efficacy and safety of gabapentin, pregabalin, oxcarbazepine, and duloxetine in diabetic peripheral neuropathy: A network meta-analysisKaran Bhavesh Shah, Devang A Rana, Yash Dharmendra Mehta, et al.
Expert Opinion on Biological Therapy|January 27, 2026
A situational analysis of the adoption of oncology, inflammation, and supportive care biosimilars in the United StatesBhavesh Shah, Josephine Kim, Ann Wicker, et al.
Journal of the Advanced Practitioner in Oncology|August 25, 2021
Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case SeriesDavid M Hughes, Charina Toste, Christopher Nelson, et al.
Pediatric Blood & Cancer|September 26, 2024
Adherence outcomes of a liquid hydroxyurea delivery program in a pediatric populationMaria A Sacta, Supriya Sarvode, Amanuel Kehasse, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Materials (Basel, Switzerland)|December 17, 2024
Measurement of Sorption Isotherms to Guide Mixed Display of Archaeological Iron, Bone, and GlassDavid Thickett, Antanas Mėlinis, Bhavesh Shah
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 21, 2022
Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myelomaBhavesh Shah, Joy Gray, Ivo Abraham, et al.
Digestive Diseases and Sciences|October 7, 2015
The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel DiseaseTaha Qazi, Bhavesh Shah, Mohammed El-Dib, et al.
Inflammatory Bowel Diseases|October 19, 2016
ReplySamantha Zullow, Sharmeel K Wasan, Bhavesh Shah, et al.
Journal of Maxillofacial and Oral Surgery|October 24, 2022
Cirsoid Aneurysm of Occipital Artery-Rare of the RarestPrashant Punia, Sonal Bhavesh Shah, Tanvi Eknath Malankar, et al.
Cureus|June 14, 2022
Accessory Spleen: A Rare and Incidental Finding in the Stomach WallSophie G Trujillo, Sherif Saleh, Ryan Burkholder, et al.
Perspectives in Clinical Research|November 25, 2024
Comparative efficacy and safety of gabapentin, pregabalin, oxcarbazepine, and duloxetine in diabetic peripheral neuropathy: A network meta-analysisKaran Bhavesh Shah, Devang A Rana, Yash Dharmendra Mehta, et al.
Expert Opinion on Biological Therapy|January 27, 2026
A situational analysis of the adoption of oncology, inflammation, and supportive care biosimilars in the United StatesBhavesh Shah, Josephine Kim, Ann Wicker, et al.
Journal of the Advanced Practitioner in Oncology|August 25, 2021
Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case SeriesDavid M Hughes, Charina Toste, Christopher Nelson, et al.
Pediatric Blood & Cancer|September 26, 2024
Adherence outcomes of a liquid hydroxyurea delivery program in a pediatric populationMaria A Sacta, Supriya Sarvode, Amanuel Kehasse, et al.
Pageof 4